Ningbo Menovo Pharmaceutical Co., Ltd.

SHSE:603538 Stock Report

Market Cap: CN¥2.9b

Ningbo Menovo Pharmaceutical Future Growth

Future criteria checks 5/6

Ningbo Menovo Pharmaceutical is forecast to grow earnings and revenue by 59% and 27.8% per annum respectively. EPS is expected to grow by 59.1% per annum. Return on equity is forecast to be 9.6% in 3 years.

Key information

59.0%

Earnings growth rate

59.1%

EPS growth rate

Pharmaceuticals earnings growth18.7%
Revenue growth rate27.8%
Future return on equity9.6%
Analyst coverage

Low

Last updated11 Nov 2024

Recent future growth updates

No updates

Recent updates

Ningbo Menovo Pharmaceutical's (SHSE:603538) Problems Go Beyond Weak Profit

Nov 05
Ningbo Menovo Pharmaceutical's (SHSE:603538) Problems Go Beyond Weak Profit

Benign Growth For Ningbo Menovo Pharmaceutical Co., Ltd. (SHSE:603538) Underpins Its Share Price

Apr 17
Benign Growth For Ningbo Menovo Pharmaceutical Co., Ltd. (SHSE:603538) Underpins Its Share Price

Earnings and Revenue Growth Forecasts

SHSE:603538 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,298255N/A4741
12/31/20251,985255N/A2702
12/31/20241,481162N/A1841
9/30/20241,2372069197N/A
6/30/20241,2420-9544N/A
3/31/20241,233-18-171-29N/A
12/31/20231,21612-2109N/A
9/30/20231,155179-535-104N/A
6/30/20231,142185-45647N/A
3/31/20231,203267-379208N/A
12/31/20221,457339-295277N/A
9/30/20221,570221-233301N/A
6/30/20221,464211-279260N/A
3/31/20221,420207-217292N/A
12/31/20211,258143-309221N/A
9/30/20211,163150-272184N/A
6/30/20211,234166-210220N/A
3/31/20211,246163-279107N/A
12/31/20201,193156-88228N/A
9/30/20201,278164-35298N/A
6/30/20201,270171-166162N/A
3/31/20201,211152-125200N/A
12/31/20191,180151-148180N/A
9/30/20191,142160-109141N/A
6/30/20191,062138-87193N/A
3/31/2019949131-169141N/A
12/31/201884996-25347N/A
9/30/201873573-20334N/A
6/30/201865057N/A45N/A
3/31/201861539N/A39N/A
12/31/201760545N/A80N/A
9/30/201756053N/A109N/A
6/30/201758471N/A133N/A
3/31/201759580N/A150N/A
12/31/201657879N/A117N/A
12/31/201559777N/A133N/A
12/31/201463673N/A75N/A
12/31/201350269N/A149N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 603538's forecast earnings growth (59% per year) is above the savings rate (2.8%).

Earnings vs Market: 603538's earnings (59% per year) are forecast to grow faster than the CN market (26.1% per year).

High Growth Earnings: 603538's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 603538's revenue (27.8% per year) is forecast to grow faster than the CN market (13.8% per year).

High Growth Revenue: 603538's revenue (27.8% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 603538's Return on Equity is forecast to be low in 3 years time (9.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y